Operating an integrated network of 50 labs the company performs over 30 million laboratory tests annually.
Matthew Strassberg, the Mid Europa partner who leads healthcare investments, said, “The acquisition of Alpha Medical represents a significant step in our strategy of consolidating the laboratory market in Central Europe by expanding our footprint beyond Poland where we invested in the market-leading operator, Diagnostyka, and Fryda.
The regional platform created through the acquisition of Alpha Medical will have the technical expertise and resources to further differentiate itself by offering its customers consistently superior quality and speed of execution. We intend to dedicate significant resources to support the platform’s continued expansion of technological and market leadership in what are some of the most attractive laboratory markets in Europe.”
Pawel Padusinski, director at the firm, added, “We have been highly impressed by the management team’s long-standing track record of implementing a successful and rapid buyand-build strategy, and look forward to working with Peter Lednicky and his team to further enhance the company’s quality of service, and support its growth both organically and through acquisitions.”
In September, AltAssets reported that Mid Europa Partners had hired Credit Suisse to place its fourth fund, which the firm is looking to launch at the beginning of next year.
Copyright © 2012 AltAssets